Expression of SMURF family in pancreatic cancer and its effect on cell proliferation and migration
High expression of SMURF1 could potentially be a therapeutic target and a poor prognostic indicator in pancreatic cancer.
Authors
- Ke Huang (ORCID: https://orcid.org/0000-0002-8257-5558)
- Haoran Zhu (ORCID: https://orcid.org/0000-0003-3879-0389)
- Lin Shi (ORCID: https://orcid.org/0000-0001-7578-7440)
- Jian Wang (ORCID: https://orcid.org/0000-0003-2291-640X)
- Chen Zhang (ORCID: https://orcid.org/0000-0001-5440-3911)
- Sai Zhao
- Yuan Wang (ORCID: https://orcid.org/0000-0002-4291-3700)
- Xu Yang (ORCID: https://orcid.org/0000-0002-9791-5615)
- Lingfei Wu (ORCID: https://orcid.org/0000-0002-0102-3613)
- Chenqi Li (ORCID: https://orcid.org/0000-0002-1289-8423)
Institutions
- Jiangsu University (CN)
- Xuzhou Medical College (CN)
- Affiliated Hospital of Jiangsu University (CN)
- Second Affiliated Hospital of Xuzhou Medical College (CN)
- Jiangsu Provincial Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.3389/fonc.2025.1538335
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Government of Jiangsu Province
- Nanjing Medical University
- Xuzhou Medical University
- Xuzhou Science and Technology Bureau